AzTrials
AzTrials

MyopiaNCT05691296

The Monitoring and Intervention of Refractive Changes in Children and Teenagers in Tianjin

A study testing Home training and School training in people with Myopia and High Myopia, run by Tianjin Eye Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study aimed to collect multi-factor information on school-age children with pre-clinical myopia, and to identify the initial factors and warning signs of myopia. Read more about this study

Who is it for?
Ages 5 to 12 years
Conditions the study is for
Myopia, High Myopia
What is being tested?
Home training and School training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
4,000 participants
Where
1 siteChina
Study dates
1 May 2020to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • All students in grades 1 to 4
  • Can cooperate with the examination of students

Who cannot join

  • Obvious strabismus and amblyopia
  • Eye diseases that affect vision, such as congenital cataracts, glaucoma, and retinal diseases
  • History of ocular surgery

Trial locations and contacts

1 site in 1 country.

China1 site
  • Tiajin Eye Hospital

    Tianjin, Tianjin Municipality, 300020

Other trials in China

About this study

The study aimed to collect multi-factor information on school-age children with pre-clinical myopia, and to identify the initial factors and warning signs of myopia.

Read the detailed description

The incidence of myopia is high in China. At present, the mechanism of myopia is unclear, and the main theories are genetic and environmental aspects. Many factors may affect the occurrence and development of myopia in students, such as ocular biological parameters, peripheral refractive state, differences in binocular vision function, eye habits, and outdoor time. In this study, the multi-factor information on pre-clinical myopia in school-age children was collected to find out the initial factors and warning signals of myopia.

Conditions
Myopia, High Myopia
Being tested
Home training, School training
Medical subject headings
Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Home trainingBehavioural

    Letter Chart Accomodative Rock Training for 2 minutes each time

  • School trainingBehavioural

    Letter Chart Accomodative Rock Training for 2 minutes each time

Study groups in NCT05691296
Study groupRoleWhat they receive
Home-school training groupExperimentalThere was a Letter Chart Accomodative Rock Training for accommodation facility at home and school everyday. This training usually lasted 2 minutes each time.
Receives: Behavioral: Home training; Behavioral: School training
School training groupExperimentalThere was a Letter Chart Accomodative Rock Training for accommodation facility only at school everyday. This training usually lasted 2 minutes each time.
Receives: Behavioral: School training
No training groupNo interventionThere was no such treatment for students.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The rate of new-onset myopia

    The number of new children with myopia was counted

    Measured: Through study completion, an average of 1 year

  2. The changes of refractive error

    The changes of refractive error between visit time and baseline which was obtained with a computer refractometer.

    Measured: Every 6 months, up to 3 years

  3. The changes of axial length

    The axial length was measured by a biological measuring instrument.

    Measured: Every 6 months, up to 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Jan 2023
  2. Study start1 May 2020
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
4,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05691296
Sponsor's protocol ID
Tianjin myopia Intervention
Status last verified
May 2024
First submitted
25 Dec 2022
Last updated
7 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Jonas JB, Ang M, Cho P, Guggenheim JA, He MG, Jong M, Logan NS, Liu M, Morgan I, Ohno-Matsui K, Parssinen O, Resnikoff S, Sankaridurg P, Saw SM, Smith EL 3rd, Tan DTH, Walline JJ, Wildsoet CF, Wu PC, Zhu X, Wolffsohn JS. IMI Prevention of Myopia and Its Progression. Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):6. doi: 10.1167/iovs.62.5.6.

    PubMed 33909032

Questions about this trial

What is this clinical trial studying?

A study testing Home training and School training in people with Myopia and High Myopia, run by Tianjin Eye Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The rate of new-onset myopia (time frame: Through study completion, an average of 1 year). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05691296, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in